{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T09:44:19Z","timestamp":1767174259355,"version":"build-2238731810"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T00:00:00Z","timestamp":1686355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T00:00:00Z","timestamp":1686355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171240"],"award-info":[{"award-number":["82171240"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870856; 81870992; 82071416"],"award-info":[{"award-number":["81870856; 81870992; 82071416"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"General Project of Basic and Applied Basic Research of Guangzhou Bureau of Science and Technology","award":["2060206"],"award-info":[{"award-number":["2060206"]}]},{"name":"Yang-cheng Scholar Project of Guangzhou Municipal Bureau of Education","award":["202032790"],"award-info":[{"award-number":["202032790"]}]},{"name":"General Project of Natural Science Foundation of Guangdong Province","award":["2021A1515011043"],"award-info":[{"award-number":["2021A1515011043"]}]},{"name":"Guangzhou Medical Key Discipline Project","award":["2021-2023"],"award-info":[{"award-number":["2021-2023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The\n                      <jats:italic>glucocerebrosidase<\/jats:italic>\n                      (\n                      <jats:italic>GBA<\/jats:italic>\n                      ) and\n                      <jats:italic>leucine-rich repeat kinase 2<\/jats:italic>\n                      (\n                      <jats:italic>LRRK2<\/jats:italic>\n                      ) genes are associated with the risk of sporadic Parkinson\u2019s disease (PD). As an environmental factor, hypoxic insults may impair dopamine neurons in the substantia nigra and exacerbate PD symptoms. However, covariants of\n                      <jats:italic>GBA<\/jats:italic>\n                      and\n                      <jats:italic>LRRK2<\/jats:italic>\n                      combined with hypoxic insults in clinical cases of Parkinsonism have not yet been reported.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      A 69-year-old male patient with PD and his relatives were clinically characterized and sequenced using the whole-exome technique. A novel covariant,\n                      <jats:italic>c.1448\u00a0T<\/jats:italic>\n                      \u2009&gt;\u2009\n                      <jats:italic>C<\/jats:italic>\n                      (\n                      <jats:italic>p. L483P<\/jats:italic>\n                      ,\n                      <jats:italic>rs421016<\/jats:italic>\n                      ) on\n                      <jats:italic>GBA<\/jats:italic>\n                      and\n                      <jats:italic>c.691\u00a0T<\/jats:italic>\n                      \u2009&gt;\u2009\n                      <jats:italic>C<\/jats:italic>\n                      (\n                      <jats:italic>p. S231P<\/jats:italic>\n                      ,\n                      <jats:italic>rs201332859<\/jats:italic>\n                      ) on\n                      <jats:italic>LRRK2<\/jats:italic>\n                      were identified in this patient who first developed bradykinesia and rigidity in the neck at one month after an acute hypoxic insult during mountaineering. The patient presented with a mask-like face, festinating gait, asymmetric bradykinesia, and moderate rigidity. These symptoms were treated with levodopa and pramipexole, resulting in a 65% improvement in the Unified Parkinson\u2019s Disease Rating Scale (UPDRS) motor score. These parkinsonian symptoms persisted and developed with hallucinations, constipation, and rapid eye movement sleep behavior disorder. After 4\u00a0years, the patient exhibited a wearing-off phenomenon and died from pulmonary infection 8\u00a0years after disease onset. His parents, wife, and siblings were not diagnosed with PD, and his son carried\n                      <jats:italic>p. L483P<\/jats:italic>\n                      without Parkinsonism-like symptoms.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      This is a case report of PD after hypoxic insult in a patient carrying a covariant of\n                      <jats:italic>GBA<\/jats:italic>\n                      and\n                      <jats:italic>LRRK2<\/jats:italic>\n                      . This study may help us understand the interaction between genetic and environmental factors in clinical PD.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-023-03269-5","type":"journal-article","created":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T02:01:37Z","timestamp":1686362497000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Parkinson\u2019s disease in a patient with GBA and LRRK2 covariants after acute hypoxic insult: a case report"],"prefix":"10.1186","volume":"23","author":[{"given":"Yuting","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuohua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pingyi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4362-8194","authenticated-orcid":false,"given":"Mingshu","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,10]]},"reference":[{"issue":"8","key":"3269_CR1","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3390\/cells11081261","volume":"11","author":"L Smith","year":"2022","unstructured":"Smith L, Schapira AH. GBA Variants and Parkinson disease: mechanisms and treatments. Cells. 2022;11(8):1261.","journal-title":"Cells"},{"issue":"2","key":"3269_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41582-019-0301-2","volume":"16","author":"E Tolosa","year":"2020","unstructured":"Tolosa E, et al. LRRK2 in Parkinson disease: challenges of clinical trials. Nat Rev Neurol. 2020;16(2):97\u2013107.","journal-title":"Nat Rev Neurol"},{"issue":"11","key":"3269_CR3","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1212\/WNL.0b013e318249f673","volume":"78","author":"R Inzelberg","year":"2012","unstructured":"Inzelberg R, et al. The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers. Neurology. 2012;78(11):781\u20136.","journal-title":"Neurology"},{"issue":"6","key":"3269_CR4","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1042\/BST20180463","volume":"47","author":"RL Wallings","year":"2019","unstructured":"Wallings RL, Tansey MG. LRRK2 regulation of immune-pathways and inflammatory disease. Biochem Soc Trans. 2019;47(6):1581\u201395.","journal-title":"Biochem Soc Trans"},{"issue":"5","key":"3269_CR5","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/mds.27974","volume":"35","author":"H Iwaki","year":"2020","unstructured":"Iwaki H, et al. Penetrance of Parkinson\u2019s disease in LRRK2 p. G2019S carriers is modified by a polygenic risk score. Mov Disord. 2020;35(5):774\u201380.","journal-title":"Mov Disord"},{"issue":"2","key":"3269_CR6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/immuno1020006","volume":"1","author":"J Burtscher","year":"2021","unstructured":"Burtscher J, Millet GP. Hypoxia, acidification and inflammation: partners in crime in Parkinson\u2019s disease pathogenesis? Immuno. 2021;1(2):78\u201390.","journal-title":"Immuno"},{"issue":"14","key":"3269_CR7","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1001\/jama.2018.0220","volume":"319","author":"F Macholz","year":"2018","unstructured":"Macholz F, Sareban M, Berger MM. Diagnosing acute mountain sickness. JAMA. 2018;319(14):1509\u20131509.","journal-title":"JAMA"},{"issue":"8","key":"3269_CR8","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/cns.13642","volume":"27","author":"J Liu","year":"2021","unstructured":"Liu J, et al. Neuroprotective effects and mechanisms of ischemic\/hypoxic preconditioning on neurological diseases. CNS Neurosci Ther. 2021;27(8):869\u201382.","journal-title":"CNS Neurosci Ther"},{"key":"3269_CR9","unstructured":"Pakarulrazy NFM et al. Glucocerebrosidase genetic variants in Malays with early and late-onset Parkinson\u2019s disease. Neurol Asia. 2020;25(1):39\u201346."},{"issue":"1","key":"3269_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00702-021-02421-0","volume":"129","author":"JL Lim","year":"2022","unstructured":"Lim JL, et al. Glucocerebrosidase (GBA) gene variants in a multi-ethnic Asian cohort with Parkinson\u2019s disease: mutational spectrum and clinical features. J Neural Transm. 2022;129(1):37\u201348.","journal-title":"J Neural Transm"},{"issue":"1","key":"3269_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1744-9081-8-57","volume":"8","author":"Y Wang","year":"2012","unstructured":"Wang Y, et al. Glucocerebrosidase L444P mutation confers genetic risk for Parkinson\u2019s disease in central China. Behav Brain Funct. 2012;8(1):1\u20135.","journal-title":"Behav Brain Funct"},{"issue":"7","key":"3269_CR12","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/mds.26593","volume":"31","author":"A G\u00e1mez-Valero","year":"2016","unstructured":"G\u00e1mez-Valero A, et al. GBA mutations are associated with earlier onset and male sex in dementia with Lewy bodies. Mov Disord. 2016;31(7):1066\u201370.","journal-title":"Mov Disord"},{"issue":"2","key":"3269_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.parkreldis.2014.11.022","volume":"21","author":"XQ Yuan","year":"2015","unstructured":"Yuan XQ, et al. An association analysis of the R1628P and G2385R polymorphisms of the LRRK2 gene in multiple system atrophy in a Chinese population. Parkinsonism Relat Disord. 2015;21(2):147\u20139.","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"3269_CR14","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1093\/hmg\/ddu538","volume":"24","author":"I Zancan","year":"2015","unstructured":"Zancan I, et al. Glucocerebrosidase deficiency in zebrafish affects primary bone ossification through increased oxidative stress and reduced Wnt\/\u03b2-catenin signaling. Hum Mol Genet. 2015;24(5):1280\u201394.","journal-title":"Hum Mol Genet"},{"key":"3269_CR15","doi-asserted-by":"publisher","first-page":"e51071","DOI":"10.7554\/eLife.51071","volume":"9","author":"GW Chi","year":"2020","unstructured":"Chi GW, et al. LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to Mycobacterium tuberculosis. eLife. 2020;9:e51071.","journal-title":"eLife"},{"issue":"4","key":"3269_CR16","doi-asserted-by":"publisher","first-page":"e215845","DOI":"10.1001\/jamanetworkopen.2021.5845","volume":"4","author":"RA Ortega","year":"2021","unstructured":"Ortega RA, et al. Association of dual LRRK2 G2019S and GBA variations with Parkinson disease progression. JAMA Netw Open. 2021;4(4):e215845.","journal-title":"JAMA Netw Open"}],"updated-by":[{"DOI":"10.1186\/s12883-024-03916-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000}}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03269-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-023-03269-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03269-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T12:03:13Z","timestamp":1729252993000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-023-03269-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,10]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3269"],"URL":"https:\/\/doi.org\/10.1186\/s12883-023-03269-5","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,10]]},"assertion":[{"value":"26 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The funding number of General Project of Basic and Applied Basic Research of Guangzhou Bureau of Science and Technology was corrected.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12883-024-03916-5","URL":"https:\/\/doi.org\/10.1186\/s12883-024-03916-5","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient gave written consent for their personal or clinical details along with any identifying images to be published in this study. A copy of the written consent is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"226"}}